HLS Therapeutics Inc. (OTCMKTS:HLTRF) Short Interest Up 3,100.0% in March

HLS Therapeutics Inc. (OTCMKTS:HLTRF) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 3,200 shares, an increase of 3,100.0% from the February 28th total of 100 shares. Based on an average daily volume of 100 shares, the days-to-cover ratio is presently 32.0 days.

HLS Therapeutics Stock Up 0.6 %

HLS Therapeutics stock opened at $3.22 on Friday. HLS Therapeutics has a 52-week low of $2.22 and a 52-week high of $4.00. The firm’s fifty day moving average is $2.86 and its 200 day moving average is $2.67.

About HLS Therapeutics

HLS Therapeutics Inc, a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. The company's product portfolio includes Clozaril, an atypical antipsychotic for management of symptoms of treatment-resistant schizophrenia; and Vascepa, an icosapent ethyl capsules for cardiovascular disease.